Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Improving decision-making for early-stage lung cancer patients

Official title: Utilizing Patient Reported Quality of Life to Inform Patient Decision Making in Early-Stage Lung Cancer

Run by Roswell Park Cancer Institute · NCT05292521 · Data updated 2026-11-12

This study is testing whether giving early-stage lung cancer patients a quality of life fact sheet during their treatment decision-making helps them feel better about their choices compared to usual care.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorRoswell Park Cancer Institute
Academic / other
Drugs / interventionsradiation
Locations1 site (Buffalo, New York)
StatusRecruiting
StartedDecember 21, 2023
Main results expectedDecember 21, 2028
Study endsDecember 21, 2028
Registry record updatedOctober 23, 2026
Trial IDNCT05292521 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older with stage I-II non-small cell lung cancer who are eligible for both surgery and SBRT.

Probably not a fit

Patients with advanced stage lung cancer (stage III-IV) or those eligible for only one treatment option may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the impact of a quality of life intervention on decision-making for patients with early-stage lung cancer who are considering standard treatment options such as surgery or stereotactic body radiation therapy (SBRT). Participants are randomly assigned to receive either a quality of life fact sheet or usual care during their initial consultation. The study aims to assess how this information affects decision regret and overall quality of life. Follow-up assessments are conducted at 1, 3, and 6 months post-treatment to gather data on patient satisfaction and outcomes.

Why it matters

Potential benefit: If successful, this intervention could enhance patient satisfaction and reduce decision regret for those facing treatment choices in early-stage lung cancer.

How similar studies have gone: Similar studies have shown that providing quality of life information can positively influence patient decision-making and satisfaction, suggesting a promising approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \>= 18 years
* Radiographic stage I-II non-small cell lung cancer (NSCLC)

  * Of note, separate tumor nodule(s) in an ipsilateral lobe different from that of the primary is considered T4 disease. However, these are treated as separate stage I or II lesions and will be eligible for this study.
* Eligible for both surgery and SBRT
* Able to provide informed consent in English
* Have verbal fluency in English
* Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure

Exclusion Criteria:

* Radiographic stage III-IV NSCLC except as noted above
* Eligible for either only surgery or SBRT, but not both
* Eligible for palliative-intent treatments or supportive care only.
* Pregnant female participants.
* Unwilling or unable to follow protocol requirements
* Any condition which in the investigator's opinion deems the participant an unsuitable candidate
* Cognitively impaired adults/adults with impaired decision-making capacity
* Individuals who are not yet adults (infants, children, teenagers)
* Prisoners

Where it's running

  • Roswell Park Cancer Institute
    Buffalo, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Anurag K Singh — Roswell Park Cancer Institute

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.